Expert: Professor Jorge Cortes Georgia Cancer Centre, Augusta (USA)

Program:
Overview of significant clinical aspects presented during the meeting, including:

00:00 Welcome & Introduction
01:36 Clinical Highlights - Jorge Cortes
02:35 Highest Scoring Abstracts
12:16 Propensity score analysis of ponatinib versus asciminib
15:25 Reports on newer TKI's

Q&A Session can be found at the end of the biological overview

If you have any questions or comments to the speaker, please email info@cml-foundation.org.